101 related articles for article (PubMed ID: 14684544)
1. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer.
Yoshida Y; Kurokawa T; Kawahara K; Tsuchida T; Okazawa H; Fujibayashi Y; Yonekura Y; Kotsuji F
AJR Am J Roentgenol; 2004 Jan; 182(1):227-33. PubMed ID: 14684544
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
4. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G
Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492
[TBL] [Abstract][Full Text] [Related]
5. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
[TBL] [Abstract][Full Text] [Related]
7. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
8. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
Picchio M; Mangili G; Samanes Gajate AM; De Marzi P; Spinapolice EG; Mapelli P; Giovacchini G; Sigismondi C; Viganò R; Sironi S; Messa C
Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
10. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT for staging of penile cancer.
Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
[TBL] [Abstract][Full Text] [Related]
12. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT.
Kitajima K; Murakami K; Yamasaki E; Kaji Y; Fukasawa I; Inaba N; Sugimura K
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1912-20. PubMed ID: 18682935
[TBL] [Abstract][Full Text] [Related]
15. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.
Picchio M; Sironi S; Messa C; Mangili G; Landoni C; Gianolli L; Zangheri B; Viganò R; Aletti G; De Marzi P; De Cobelli F; Del Maschio A; Ferrari A; Fazio F
Q J Nucl Med; 2003 Jun; 47(2):77-84. PubMed ID: 12865867
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.
Cho SM; Ha HK; Byun JY; Lee JM; Kim CJ; Nam-Koong SE; Lee JM
AJR Am J Roentgenol; 2002 Aug; 179(2):391-5. PubMed ID: 12130439
[TBL] [Abstract][Full Text] [Related]
17. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings.
Rieber A; Nüssle K; Stöhr I; Grab D; Fenchel S; Kreienberg R; Reske SN; Brambs HJ
AJR Am J Roentgenol; 2001 Jul; 177(1):123-9. PubMed ID: 11418411
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.
Nam EJ; Yun MJ; Oh YT; Kim JW; Kim JH; Kim S; Jung YW; Kim SW; Kim YT
Gynecol Oncol; 2010 Mar; 116(3):389-94. PubMed ID: 19926121
[TBL] [Abstract][Full Text] [Related]
19. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
Gynecol Oncol; 2010 Mar; 116(3):395-8. PubMed ID: 20042226
[TBL] [Abstract][Full Text] [Related]
20. Role of PET/CT in ovarian cancer.
Prakash P; Cronin CG; Blake MA
AJR Am J Roentgenol; 2010 Jun; 194(6):W464-70. PubMed ID: 20489063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]